Sleep disordered breathing in Parkinson's disease: A critical appraisal

Sleep Medicine Reviews

Volumn 18, Issue 2, 2014, Pages 173-178

  Da Silva Júnior, Francisco P ^a   do Prado, Gilmar F ^b   Barbosa, Egberto R ^a   Tufik, Sergio ^b   Togeiro, Sônia M ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiovascular diseases; Parkinson disease; Sleep disordered breathing

Indexed keywords

CARDIOVASCULAR DISEASES; PARKINSON DISEASE; SLEEP DISORDERED BREATHING;

COMORBIDITY; HUMANS; PARKINSON DISEASE; PREVALENCE; SLEEP APNEA SYNDROMES;

EID: 84895038683     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2013.04.005     Document Type: Review

References (62)

1. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
2. De Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5:525-535.
3. Bernal-Pacheco O., Limotai N., Go C.L., Fernandez H.H. Nonmotor manifestations in Parkinson disease. Neurologist 2012, 18:1-16.
4. Chaudhuri K.R., Odin P., Antonini A., Martinez-Martin P. Parkinson's disease: the non-motor issues. Parkinsonism Relat Disord 2011, 17:717-723.
5. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T.P., et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009, 24:1641-1649.
6. Simuni T., Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008, 64:S65-S80.
7. Gallagher D.A., Lees A.J., Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them. Mov Disord 2010, 25:2493-2500.
8. Menza M., Dobkin R.D., Marin H., Gara M., Bienfait K., Dicke A., et al. Treatment of insomnia in Parkinson's disease: a controlled trial with eszopiclone and placebo. Mov Disord 2010, 25:1708-1714.
9. Oerlemans W.G., de Weerd A.W. The prevalence of sleep disorders in patients with Parkinson's disease. A self-reported, community-based survey. Sleep Med 2002, 3:147-149.
10. Tandberg E., Larsen J.P., Karlsen K. Acommunity-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998, 13:895-899.
11. Abbott R.D., Ross G.W., White L.R., Tanner C.M., Masaki K.H., Nelson J.S., et al. Excessive daytime sleepiness and subsequent development of Parkinson's disease. Neurology 2005, 65:1442-1446.
12. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005, 9:185-200.
13. Tolosa E., Gaig C., Santamaría J., Compta Y. Diagnosis of the premotor phase of Parkinson disease. Neurology 2009, 72:S12-S20.
14. Braga-Neto P., da Silva-Júnior F.P., Monte F.S., Bruin P.F., Bruin V.M. Snoring and excessive daytime sleepiness in Parkinson's disease. JNeurol Sci 2004, 217:41-45.
15. Maria B., Sophia S., Michalis M., Charalampos L., Andreas P., John M.E., et al. Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir Med 2003, 97:1151-1157.
16. Diederich N.J., McIntyre D.J. Sleep disorders in Parkinson's disease: many causes, few therapeutic options. JNeurol Sci 2012, 314:12-19.
17. Bruin V.M., Bittencourt L.R., Tufik S. Sleep-wake disturbances in Parkinson's disease: current evidence regarding diagnostic and therapeutic decisions. Eur Neurol 2012, 67:257-267.
18. Zoccolella S., Svarese M., Lamberti P., Manni R., Pacchetti C., Logroscino G. Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies. Sleep Med Rev 2011, 15:41-50.
19. Tufik S., Santos-Silva R., Taddei J.A., Bittencourt L.R. Obstructive sleep apnea syndrome in the São Paulo Epidemiologic Sleep Study. Sleep Med 2010, 11:441-446.
20. Ramar K., Caples S.M. Cardiovascular consequences of obese and nonobese obstructive sleep apnea. Med Clin N Am 2010, 94:465-478.
21. Sánchez-de-la-Torre M., Campos-Rodrigues F., Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 2013, 1:61-72.
22. Leroi I., McDonald K., Pantula H., Harbishettar V. Cognitive impairment in Parkinson disease: impact on quality of life, disability and caregiver burden. JGeriatr Psychiatry Neurol 2012, 25:208-214.
23. Taylor J.M., Main B.S., Crack P.J. Neuroinflammation and oxidative stress: co-conspirators in pathology of Parkinson's disease. Neurochem Int 2013, 62:803-819.
24. Olanow C.W. The pathogenesis of cell death in Parkinson's disease. Mov Disord 2007, 22:S335-S342.
25. Xiang W., Schlachetzki J.C., Helling S., Bussmann J.C., Berlinghof M., Schaffer T.E., et al. Oxidative stress-induced posttranslational modificationsof alpha-synuclein: specific modifications of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Moll Cell Neurosci 2013, 54:71-83.
26. Ferini-Strambi L., Franceschi M., Pinto P., Zucconi M., Smirne S. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992, 38:92-98.
27. Diederich N.J., Vaillant M., Leischen M., Mancuso G., Golinval S., Nati R., et al. Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov Disord 2005, 20:1413-1418.
28. Shpirer I., Miniovitz A., Klein C., Goldstein R., Prokhorov T., Theitler J., et al. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study. Mov Disord 2006, 21:1432-1438.
29. De Cock V.C., Abouda M., Leu S., Oudiette D., Roze E., Vidailhet M., et al. Is obstructive sleep apnea a problem in Parkinson's disease?. Sleep Med 2010, 11:247-252.
30. Trotti L.M., Bliwise D.L. No increased risk of obstructive sleep apnea in Parkinson's disease. Mov Disord 2010, 25:2246-2249.
31. Yong M.H., Fook-Chong S., Pavanni R., Lim L.L., Tan E.K. Case control polysomnographic studies of sleep disorders in Parkinson's disease. PLoS One 2011, 6:e22511.
32. Young A., Horne M., Churchward T., Freezer N., Holmes P., Ho M. Comparison of sleep disturbance in mild versus severe Parkinson's disease. Sleep 2002, 25:568-572.
33. Arnulf I., Konofal E., Merino-Andreu M., Houeto J.L., Mesnage V., Welter M.L., et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002, 58:1019-1024.
34. Norlinah M.I., Afidah K.N., Noradina A.T., Shamsul A.S., Hamidon B.B., Sahathevan R. Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS. Parkinsonism Relat Disord 2009, 15:670-674.
35. Poryazova R., Benninger D., Waldvogel D., Bassetti C.L. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol 2010, 63:129-135.
36. 11C]study DASB PET imaging study. PLoS One 2012, 7:e40166.
37. Ondo W.G., Perkins T., Swick T., Hull K.L., Jimenez J.E., Garris T.S., et al. Sodium oxybate for excessive daytime sleepiness in Parkinson's disease; an open-label polysomnographic study. Arch Neurol 2008, 65:1337-1340.
38. Medeiros C.A., Bruin P.F., Lopes L.A., Magalhães M.C., Seabra M.L., Bruin V.M. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. JNeurol 2007, 254:459-464.
39. Nieto F.J., Young T.B., Lind B.K., Shahal E., Samet J.M., Redline S., et al. Association ofsleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart health Study. JAMA 2000, 283:1829-1836.
40. Ruehland W.R., Rochford P.D., O'Donoghue F.J., Pierce R.J., Singh P., Thornton A.T. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 2009, 32:150-157.
41. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.M., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
42. Vincken W.G., Gauthier S.G., Dollfuss R.E., Hanson R.E., Darauay C.M., Cosio M.G. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. NEngl J Med 1984, 311:438-442.
43. De Bruin P.F., de Bruin V.M., Lees A.J., Pride N.B. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease. Am Rev Respir Dis 1993, 148:1576-1580.
44. Brown L.K. Respiratory dysfunction in Parkinson's disease. Clin Chest Med 1994, 15:715-727.
45. Herer B., Arnulf I., Housset B. Effects of levodopa on pulmonary function in Parkinson's disease. Chest 2001, 119:387-393.
46. Van der Marck M.A., Dicke H.C., Uc E.Y., Kentin Z.H., Borm G.F., Bloem B.R., et al. Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 2012, 18:263-267.
47. Jordan A.S., White D.P., Lo Y.L., Wellman A., Eckert D.J., Yim-Yeh S., et al. Airway dilator muscle activity and lung volume during stable breathing in obstructive sleep apnea. Sleep 2009, 32:361-368.
48. Fenik V.B., Davis R.O., Kubin L. REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs. Am J Respir Crit Care Med 2005, 172:1322-1330.
49. Sériès F., Cormier Y., La Forge J. influence of apnea type and sleep stage on nocturnal postapneic desaturation. Am Rev Respir Dis 1990, 141:1522-1526.
50. Findley L.J., Wilhoit S.C., Suratt P.M. Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. Chest 1985, 87:432-436.
51. Siddiqui F., Walters A.S., Goldstein D., Lahey M., Desai H. Half of patients with obstructive sleep apnea have a higher NREM AHI than REM AHI. Sleep Med 2006, 7:281-285.
52. Mokhlesi B., Punjabi N.M. "REM-related" obstructive sleep apnea: an epiphenomenon or a clinically important entity?. Sleep 2011, 35:5-7.
53. Huang J., Zhang J., Lam S.P., Li S.X., Ho C.K., Lam V., et al. Amelioration of obstructive sleep apnea in REM sleep behavior disorder: implications for the neuromuscular control of OSA. Sleep 2011, 34:909-915.
54. Norman D., Loredo J.S. Obstructive sleep apnea in older adults. Clin Geriatr Med 2008, 24:151-165.
55. Ancoli-Israel S. Sleep apnea in older adults - is it real and should age be the determining factor in the treatment decision matrix?. Sleep Med Rev 2007, 11:83-85.
56. Launois S.H., Pépin J.L., Lévy P. Sleep apnea in the elderly: a specific entity?. Sleep Med Rev 2007, 11:87-97.
57. Lavie P., Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnoea. JSleep Res 2009, 18:397-403.
58. Yamamoto T., Tamura N. Autonomic features in Parkinson's disease. Brain Nerve 2012, 64:394-402.
59. Sauvageot N., Vaillant M., Diederich N.J. Reduced sympathetically driven heart rate variability during sleep in Parkinson's disease: a case-control polysomnography-based study. Mov Disord 2011, 26:234-240.
60. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. JClin Invest 1995, 96:1897-1904.
61. Valko P.O., Hauser S., Werth E., Waldvogel D., Baumann C.R. Heart rate variability in patients with idiopathic Parkinson's disease with and without obstructive sleep apnea syndrome. Parkinsonism Relat Disord 2012, 18:525-531.
62. Högl B. Sleep apnea in Parkinson's disease: when is it significant?. Sleep Med 2010, 11:233-235.